Moderate Democrats Introduce Rival Drug Pricing Plan, Imperiling Pelosi-Backed Proposal

5Mind. The Meme Platform
The Epoch Times Logo

A group of five moderate Democrats on Tuesday unveiled a new bill to slash drug costs, signaling their party may be unable to muster enough votes to pass a larger drug pricing proposal.

The larger plan is backed by House Speaker Nancy Pelosi (D-Calif.) and President Joe Biden. It is part of of congressional Democrats $3.5 trillion budget package. It includes letting Medicare negotiate drug prices.

But Democrats can only afford so many defections, clinging to an eight-member majority in the lower chamber. And the new bill is seen by some as a direct challenge to the larger plan, which is being marked up by the House Energy and Commerce Committee.

Rep. Kathleen Rice (D-N.Y.), one of the sponsors of the new bill, a member of the panel, and a critic of Pelosi in the past, indicated as much, telling news outlets in a statement, “I support many of the proposals being considered this week, but I do not support advancing policies that are not fiscally responsible and jeopardize the bill’s final passage.”

“We need to be serious about how to address this issue by ensuring we champion legislation with broadly supported policies that have the bipartisan, bicameral backing needed to pass Congress,” Rep. Kurt Schrader (D-Ore.) added. “I do not believe the drug pricing provision before the Energy and Commerce Committee today will meet this goal and succeed in the Senate, so I cannot vote in favor of the title.”

The bill (pdf) would let Medicare negotiate drug prices, but only for a subset of drugs that no longer have competition because they lack exclusivity. It would also limit price increases on some drugs and eliminate loopholes in law dealing with pricing.

“Nobody should have to choose between putting food on the table and filling a prescription. Our plan will drastically lower out-of-pocket drug costs for consumers, as Democrats have promised, while we preserve American jobs and investment in future innovation,” Rep. Scott Peters (D-Calif.) said in a statement.

Reps. Stephanie Murphy (D-Fla.) and Lou Correa (D-Calif.) also sponsored the new bill.

By Zachary Stieber

Read Full Article on TheEpochTimes.com

To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs PDF

rccca_bill_text_xml

Contact Your Elected Officials
The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

When Institutional Language Becomes Policy

Frequency, tone, repetition, thematic emphasis, and omission can now be studied across large bodies of text. Patterns once dismissed as anecdotal can be analyzed and tested.

America In Crisis: The Clueless Masses Need To Wake Up!

There seems to be a growing number of Americans who believe this country is some horrible, oppressive nightmare.

Breaching constitutional limits

Bill 1957 would restructure Pennsylvania’s constitution and give abortion and a wide range of “personal reproductive decisions” legal protection.

Chasing the NIL mirage

The Wall Street Journal’s recent dive into Florida’s high school transfer free-for-all should awaken every parent, educator, and legislator.

Corporate Profit Margins Hit All-Time High as Small Doritos Bags Retail at $5.99

Corporate profit margins and raw corporate profits are at record highs, but it’s the margins that really beg questions.

Missouri Supreme Court Upholds New Congressional Map

The Missouri Supreme Court on May 12 upheld the state’s 2025 redistricting map, possibly flipping one more seat to Republican from Democrat.

South Carolina Senate Votes Against Extending Session, Putting Redistricting in Jeopardy

South Carolina’s Senate voted not to extend its session, delaying efforts to postpone congressional primaries and redraw the state’s congressional map.

Kevin Warsh Cleared by Senate for 14‑Year Fed Board Seat

The U.S. Senate voted 51–45 to approve Kevin Warsh’s nomination to a 14-year term on the central bank’s board on May 12, joining six other members.

FDA Commissioner Marty Makary Resigns

Dr. Marty Makary wrote in a text to Trump that he was resigning, effective Tuesday. Makary did not provide a reason for the resignation.

Trump Heading to China for High-Stakes Summit With Xi

President Trump is set to depart Washington for China, where he will meet with Chinese leader Xi Jinping for a high-stakes summit.

Tech, Business Leaders Set to Accompany Trump on China Trip

President Trump is bringing a delegation of business executives when he travels to China for a summit with Chinese Communist Party leader Xi Jinping.

Trump Nominates FEMA Lead Fired From Role a Year Ago

The WH released a list of nominees for various positions across the federal government, including former Navy SEAL Cameron Hamilton to take over aa lead.

What to Know About Trump’s Presidential Fitness Test Award Revival

In the coming academic year, old-fashioned calisthenics, timed runs, and the spirit of competition could return to many public schools.
spot_img

Related Articles

Popular Categories

MAGA Business Central